Get the Stockscreener App
3.47
0.58%
0.02
After Hours:
3.50
0.03
+0.86%
Polypid Ltd stock is traded at $3.47, with a volume of 26,236.
It is up +0.58% in the last 24 hours and up +1.46% over the past month.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
See More
Previous Close:
$3.45
Open:
$3.46
24h Volume:
26,236
Relative Volume:
0.17
Market Cap:
$55.16M
Revenue:
-
Net Income/Loss:
$-23.87M
P/E Ratio:
-0.1764
EPS:
-19.67
Net Cash Flow:
$-47.63M
1W Performance:
+0.58%
1M Performance:
+1.46%
6M Performance:
+19.66%
1Y Performance:
-3.34%
1-Day Range:
$3.44
$3.5055
1-Week Range:
$3.38
$3.53
52-Week Range:
$2.30
$3.93
Polypid Ltd Stock (PYPD) Company Profile
Compare PYPD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PYPD
Polypid Ltd
|
3.47 | 54.85M | 0 | -23.87M | -47.63M | -19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Polypid Ltd Stock (PYPD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-05-25 | Initiated | Roth Capital | Buy |
| Jun-02-25 | Resumed | H.C. Wainwright | Buy |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Sep-14-21 | Initiated | JMP Securities | Mkt Outperform |
| Jul-30-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-24-20 | Upgrade | Raymond James | Outperform → Strong Buy |
| Aug-10-20 | Initiated | Alliance Global Partners | Buy |
| Jul-21-20 | Initiated | BMO Capital Markets | Outperform |
| Jul-21-20 | Initiated | Barclays | Overweight |
| Jul-21-20 | Initiated | Raymond James | Outperform |
View All
Polypid Ltd Stock (PYPD) Latest News
How to track smart money flows in PolyPid Ltd.July 2025 Movers & Daily Oversold Bounce Ideas - Newser
PolyPid Ltd. stock daily chart insights2025 Year in Review & Reliable Entry Point Trade Alerts - Newser
Using Python tools to backtest PolyPid Ltd. strategiesDividend Hike & Real-Time Stock Entry Alerts - Newser
Will PolyPid Ltd. stock recover after recent dropAnalyst Upgrade & Low Drawdown Investment Strategies - Newser
Is PolyPid Ltd. building a consolidation base2025 Dividend Review & Long-Term Growth Portfolio Plans - Newser
Can PolyPid Ltd. hit a new high this monthJuly 2025 Big Picture & Risk Managed Investment Entry Signals - Newser
What momentum shifts mean for PolyPid Ltd.Volume Spike & Community Verified Swing Trade Signals - Newser
Using economic indicators to assess PolyPid Ltd. potentialTrade Volume Report & Short-Term Trading Opportunity Alerts - Newser
Long term hold vs stop loss in PolyPid Ltd.July 2025 Weekly Recap & Weekly Momentum Picks - Newser
What MACD signals say about PolyPid Ltd.Market Activity Recap & AI Optimized Trade Strategies - Newser
Is PolyPid Ltd. meeting your algorithmic filter criteriaMarket Growth Report & Daily Volume Surge Signals - Newser
can polypid ltd. hit a new high this monthMarket Performance Recap & Stock Portfolio Risk Management - Newser
Volume spikes in PolyPid Ltd. stock – what they meanTrade Performance Summary & Weekly Watchlist of Top Performers - Newser
What’s the recovery path for long term holders of PolyPid Ltd.Forecast Cut & Daily Risk Controlled Trade Plans - Newser
Statistical indicators supporting PolyPid Ltd.’s strength2025 Market Outlook & AI Forecast Swing Trade Picks - Newser
Published on: 2025-09-11 19:16:53 - Newser
What recovery options are there for PolyPid Ltd.Earnings Overview Summary & Free High Return Stock Watch Alerts - Newser
How institutional ownership impacts PolyPid Ltd. stockDollar Strength & Fast Moving Stock Trade Plans - Newser
Real time alert setup for PolyPid Ltd. performanceJuly 2025 Review & Entry Point Confirmation Alerts - Newser
Pattern recognition hints at PolyPid Ltd. upsideJuly 2025 Chart Watch & Advanced Technical Analysis Signals - Newser
Can PolyPid Ltd. rally from current levelsWatch List & Weekly Momentum Picks - Newser
Forecasting PolyPid Ltd. price range with options dataJuly 2025 Opening Moves & Pattern Based Trade Signal System - Newser
How high can PolyPid Ltd. stock go2025 Momentum Check & Fast Moving Stock Watchlists - Newser
How to interpret RSI for PolyPid Ltd. stockJuly 2025 Analyst Calls & Free Long-Term Investment Growth Plans - Newser
Published on: 2025-09-09 22:58:31 - Newser
Short interest data insights for PolyPid Ltd.Weekly Trend Summary & Verified Momentum Stock Ideas - Newser
Will breakout in PolyPid Ltd. lead to full recoveryBull Run & Verified Technical Signals - Newser
Does PolyPid Ltd. fit your quant trading model2025 Pullback Review & Stock Portfolio Risk Management - Newser
Live Scanner Shows Breakout on PolyPid Ltd.Trade Ideas & Fast Momentum Entry Tips - beatles.ru
Detecting price anomalies in PolyPid Ltd. with AITrade Exit Report & Advanced Swing Trade Entry Plans - Newser
How to build a dashboard for PolyPid Ltd. stockQuarterly Profit Report & AI Forecasted Entry and Exit Points - Newser
Polypid Ltd Stock (PYPD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):